Ashlyn Pinto
Impact in
- Economics and Econometrics top 5%
- Health Systems, Economic Evaluations, Quality of Life
- Economic and Financial Impacts of Cancer
- Pharmaceutical Economics and Policy
- Statistics and Probability top 5%
- Statistical Methods in Clinical Trials
Papers in
-
- Retinal and Optic Conditions 3
- Glaucoma and retinal disorders 2
- Retinal Diseases and Treatments 2
-
- Corneal surgery and disorders 2
- Co-authors
- Huseyin Naci (2 shared papers)Elita Poplavska (1 shared paper)Ajay Aggarwal (1 shared paper)Courtney Davis (1 shared paper)Evrim Gurpinar (1 shared paper)Elías Mossialos (1 shared paper)Theodore J. Witek (2 shared papers)Natasha Y. Sheikhan (2 shared papers)
- Journals
- JAMA Network Open (1 paper)Cornea (1 paper)American Journal of Ophthalmology (1 paper)BMJ (1 paper)Value in Health (1 paper)
- Partner nations
- CanadaUnited KingdomUnited States
In The Last Decade
Ashlyn Pinto
7 papers receiving 416 citations
Ashlyn Pinto's Hit Papers
Peers
Comparison fields: 5 of 79
- Economics and Econometrics 262
- Statistics and Probability 59
- Oncology 95
- Cancer Research 47
- Pharmacology 26
Countries citing papers authored by Ashlyn Pinto
This map shows the geographic impact of Ashlyn Pinto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ashlyn Pinto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ashlyn Pinto more than expected).
Fields of papers citing papers by Ashlyn Pinto
This network shows the impact of papers produced by Ashlyn Pinto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ashlyn Pinto. The network helps show where Ashlyn Pinto may publish in the future.
Co-authors
The 21 scholars most cited alongside Ashlyn Pinto, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Availability of evidence of benefits on overall survival and quality of life of cancer drugs approved by European Medicines Agency: retrospective cohort study of drug approvals 2009-13 Hit paper breakdown → | 2017 | 376 |
| 2 | 2020 | 18 | |
| 3 | 2021 | 17 | |
| 4 | 2021 | 13 | |
| 5 | 2021 | 4 | |
| 6 | 2023 | 1 | |
| 7 | 2024 | 1 | |
| 8 | 2024 | 0 | |
| 9 | 2024 | 0 | |
| 10 | 2023 | 0 |
About Ashlyn Pinto
Ashlyn Pinto is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging, Economics and Econometrics, Surgery and Pharmacology, having authored 10 papers that have together received 430 indexed citations. Recurring topics across this work include Retinal and Optic Conditions (3 papers), Glaucoma and retinal disorders (2 papers), Corneal surgery and disorders (2 papers), Health Systems, Economic Evaluations, Quality of Life (2 papers), Economic and Financial Impacts of Cancer (2 papers), Retinal Diseases and Treatments (2 papers), Pharmaceutical Economics and Policy (2 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (1 paper). The work is most often cited by research in Economics and Econometrics (262 citations), Statistics and Probability (59 citations), Oncology (95 citations), Cancer Research (47 citations) and Pharmacology (26 citations). Ashlyn Pinto has collaborated with scholars based in Canada, United Kingdom and United States. Frequent co-authors include Huseyin Naci, Elita Poplavska, Ajay Aggarwal, Courtney Davis, Evrim Gurpinar, Elías Mossialos, Theodore J. Witek, Natasha Y. Sheikhan, Dominik Alex Nowak and R. Rishi Gupta. Their work appears in journals such as JAMA Network Open, Cornea, American Journal of Ophthalmology, BMJ and Value in Health.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.